{"id":144,"date":"2012-10-21T03:51:58","date_gmt":"2012-10-21T03:51:58","guid":{"rendered":""},"modified":"2012-10-21T03:51:58","modified_gmt":"2012-10-21T03:51:58","slug":"09302012-%e4%b8%81%e5%85%83%e5%8d%8e%e5%8d%9a%e5%a3%ab%e4%b8%80%e5%b8%ad%e8%b0%88","status":"publish","type":"post","link":"https:\/\/tsinghua-boston.org\/wp-based\/2012\/thaaevents\/144","title":{"rendered":"[09\/30\/2012] \u4e01\u5143\u534e\u535a\u58eb\u4e00\u5e2d\u8c08"},"content":{"rendered":"<div class=\"field_image\">\n<div>\u56fe\u7247<\/div>\n<p><img decoding=\"async\" src=\"http:\/\/tsinghua-boston.org\/wp-based\/wp-content\/uploads\/photo-ding.JPG\" title=\"photo-ding.JPG\" alt=\"photo-ding.JPG\" \/><\/div>\n<div class=\"body\">\n<div>\u6b63\u6587<\/div>\n<div>\u542c\u8f89\u745e\u516c\u53f8External R&#038;D Innovation Senior Director\u4e01\u5143\u534e\u535a\u58eb\u4e00\u5e2d\u8c08<\/p>\n<p>\u65f6\u95f4: Sunday, September 30, 2012 , 2:00 p.m.-3:30 p.m.<\/p>\n<p>\u5730\u70b9: MIT Sloan E51-372.  Address: 2 Amherst Street, Cambridge, MA<\/p>\n<p>\u4e3b\u529e\uff1a\u6ce2\u58eb\u987f\u6e05\u534e\u6821\u53cb\u4f1a\uff0c\u672a\u540d\u7d2b\u8346\u521b\u4e1a\u8054\u76df<\/p>\n<p>\u534f\u529e\uff1aMIT CSSA<\/p>\n<p>\u5609\u5bbe\u4ecb\u7ecd\uff1a<\/p>\n<p>Dr. Yuan-Hua Ding is a Senior Director and Head of Pfizer External R&#038;D Innovation (ERDI) &#8211; Asia\/Pacific, Pfizer Worldwide Research &#038; Development (WRD). He is also a member of the ERDI leadership team. In<br \/>\nthis capacity, he partners with colleagues in ERDI and Pfizer Business Development Group to evaluate academic &#038; biotech research capabilities in Asia\/Pacific region, seek opportunities to incubate early biotech<br \/>\ncompanies, build and manage a research network of academic institutes, biotech companies and Contracted Research Organizations (CROs). He liaises with therapeutic area and technology research unit leaderships in accessing the sciences, technologies and products needed to support Pfizer mission in Asia. Since June 2011, Dr. Yuan-Hua Ding also acts as Interim Head of ERDI Anti-Infective, leading a cross functional team to search and seek external novel anti-infective programs by working with biotech and pharmaceutical companies globally.<\/p>\n<p>Prior to his current role, Dr. Ding served a variety of roles in the Pfizer R&#038;D division, including Head of Asia External Science and Technology, Head of Structural Biology at the RTC Research Technology Center (RTC) in Cambridge, MA, Associate Research Fellow and Senior Research Scientist. As the Head of the RTC Structural Biology, he oversaw a group of scientists responsible for protein production, characterization, crystallization, crystallography and structure-based drug design. His group supported structural based drug design portfolio of 10+ programs, through collaborative effort between RTC, Pfizer global structural biology groups and therapeutic area project teams, covering oncology, diabetes, inflammation and CNS. He also served as project leaders for several drug discovery programs.<\/p>\n<p>Dr. Ding received a bachelor&#8217;s degree in Electronic Engineering from Peking University in 1987 and a master&#8217;s degree in Biophysics from Tsinghua University in 1990. In 1996, after completed his doctoral studies in Biochemistry with Prof. John Rosenberg and Roger Hendrix at the University of Pittsburgh, he moved to Harvard University to be a postdoctoral fellow with Prof. Don Wiley. Dr. Ding&#8217;s postdoctoral work<br \/>\nfocused on structural and biophysical aspects of molecular interactions among T-cell receptor (TCR), major histocompatibility complex (TCR) and peptide antigens. While in Dr. Wiley&#8217;s Lab, Dr Ding also collaborated with Dr. Judah Folkman of Boston Children&#8217;s Hospital on structural studies of endostatin, a protein shown to be a potent angiogenesis inhibitor in mouse model.<\/p>\n<p>Dr. Yuan-Hua Ding is the founder and secretary of the New England Structural Biology Association, a non-profit organization dedicated to bringing together industrial scientists with a shared version of using protein structures to enable the design of novel therapeutics. Dr. Ding also serves on the Editorial Board for the Chemical Biology and Drug Design journal.<\/p>\n<p>\u6ce2\u58eb\u987f\u6e05\u534e\u6821\u53cb\u4f1a\u6210\u7acb\u4e8e1976\u5e74\u3002\u81ea\u6210\u7acb\u4ee5\u6765\uff0c\u6821\u53cb\u4f1a\u4e00\u76f4\u81f4\u529b\u4e8e\u670d\u52a1\u5728\u6ce2\u58eb\u987f\u5730\u533a\u5b66\u4e60\u3001\u5de5\u4f5c\u548c\u751f\u6d3b\u7684\u6e05\u534e\u6821\u53cb\uff08\u5305\u62ec\u5317\u4eac\u6e05\u534e\u5927\u5b66\u548c\u65b0\u7af9\u56fd\u7acb\u6e05\u534e\u5927\u5b66\uff09\u3002\u6797\u5bb6\u7fd8\u3001\u674e\u8bd7\u9896\u7b49\u8457\u540d\u534e\u4eba\u79d1\u5b66\u5bb6\u90fd\u5148\u540e\u62c5\u4efb\u8fc7\u6821\u53cb\u4f1a\u4f1a\u957f\u30022011\u5e74\uff0c\u6ce2\u58eb\u987f\u6e05\u534e\u6821\u53cb\u4f1a\u5f97\u5230\u7f8e\u56fd\u8054\u90a6\u653f\u5e9c\u6279\u51c6\uff0c\u88ab\u8ba4\u5b9a\u4e3a\u7b26\u5408501(c)(3)\u514d\u7a0e\u6761\u6b3e\u7684\u516c\u5171\u6148\u5584\u673a\u6784(Public Charity)\u3002\u6ce2\u58eb\u987f\u5730\u533a\u73b0\u6709\u7ea62000\u540d\u6e05\u534e\u6821\u53cb\uff0c\u5206\u5e03\u5728\u5b66\u672f\uff0c\u6559\u80b2\uff0c\u751f\u7269\uff0c\u5236\u836f\uff0c\u7535\u5b50\uff0c\u4fe1\u606f\uff0c\u91d1\u878d\u670d\u52a1\uff0c\u5efa\u7b51\u8bbe\u8ba1\uff0c\u6cd5\u5f8b\u670d\u52a1\u7b49\u591a\u4e2a\u884c\u4e1a\u3002\u6ce2\u58eb\u987f\u6e05\u534e\u6821\u53cb\u4f1a\u7684\u5b97\u65e8\u662f<\/p>\n<p>\u8054\u8c0a\u4e0e\u4e92\u52a9\uff1b\u804c\u4e1a\u6210\u957f\u4e0e\u53d1\u5c55\uff1b\u56de\u9988\u6bcd\u6821\u4e0e\u793e\u4f1a\u3002\u6ce2\u58eb\u987f\u6e05\u534e\u6821\u53cb\u4f1a\u7f51\u7ad9\uff1ahttp:\/\/www.tsinghua-boston.org\/<br \/>\n\u672a\u540d\u7d2b\u8346\u521b\u4e1a\u8054\u76df\u7531\u6ce2\u58eb\u987f\u6e05\u534e\u5927\u5b66\u6821\u53cb\u4f1a\uff0c\u5317\u4eac\u5927\u5b66\u65b0\u82f1\u683c\u5170\u6821\u53cb\u4f1a\u8054\u5408\u6253\u9020\uff0c\u81f4\u529b\u4e8e\u5ac1\u63a5\u7f8e\u56fd\u4e1c\u90e8\u5730\u533a\u521b\u4e1a\u4eba\u624d\u4e0e\u56fd\u5185\u56ed\u533a\u7684\u521b\u4e1a\u8d44\u6e90\uff0c\u4e3a\u6709\u521b\u4e1a\u60f3\u6cd5\u7684\u5e74\u8f7b\u6821\u53cb\u642d\u5efa\u76f8\u4e92\u4ea4\u6d41\u3001\u542f\u53d1\u3001\u5408\u4f5c\u521b\u4e1a\u7684\u5e73\u53f0\u3002\u8054\u76df\u5b9a\u4f4d\u4e8e\u5f3a\u8c03&#8221;\u5b9e\u8df5&#8221;\u521b\u4e1a\u60f3\u6cd5\uff0c\u6d3b\u52a8\u5c06\u4e3b\u8981\u4ee5&#8221;\u98ce\u66b4\u8ba8\u8bba&#8221;\u5f62\u5f0f\u4e3a\u4e3b\uff0c\u6bcf\u4e00\u671f\u8bbe\u7acb\u4e00\u4e2a\u4e3b\u9898\uff0c\u4e3b\u9898\u6216\u6e90\u4e8e\u4ff1\u4e50\u90e8\u6210\u5458\u7684\u521b\u4e1a\u9879\u76ee\u3001\u6216\u6e90\u4e8e\u4ff1\u4e50\u90e8\u6210\u5458\u96c6\u4e2d\u5173\u5fc3\u7684\u70ed\u70b9\u95ee\u9898\uff0c\u5e76\u8f85\u4ee5\u6821\u53cb\u4f01\u4e1a\u53c2\u89c2\uff0c\u8bb2\u5ea7\uff0c\u7ec4\u56e2\u56de\u56fd\u8003\u5bdf\u7b49\u6d3b\u52a8\u3002\u7aed\u8bda\u9080\u8bf7\u60a8\u901a\u8fc7\u4ee5\u4e0b\u94fe\u63a5\u52a0\u5165\u6211\u4eec\u8054\u76df<br \/>\n http:\/\/groups.google.com\/group\/alumni-venturepractice-club?hl=en.<br \/>\n\u672a\u540d\u7d2b\u8346\u521b\u4e1a\u8054\u76df\u7f51\u7ad9\uff1awww.weimingzijing.com<\/p>\n<\/div>\n<\/div>\n<div class=\"field_abstract\">\n<div>\u65b0\u95fb\u6458\u8981<\/div>\n<div> \u542c\u8f89\u745e\u516c\u53f8External R&#038;D Innovation Senior Director\u4e01\u5143\u534e\u535a\u58eb\u4e00\u5e2d\u8c08<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u56fe\u7247 \u6b63\u6587 \u542c\u8f89\u745e\u516c\u53f8External R&#038;D Innovation Senior Director\u4e01\u5143\u534e\u535a\u58eb\u4e00\u5e2d\u8c08 \u65f6\u95f4: Sunday, September 30, 2012 , 2:00 p.m.-3:30 p.m. \u5730\u70b9: MIT Sloan E51-372. Address: 2 Amherst Street, Cambridge, MA \u4e3b\u529e\uff1a\u6ce2\u58eb\u987f\u6e05\u534e\u6821\u53cb\u4f1a\uff0c\u672a\u540d\u7d2b\u8346\u521b\u4e1a\u8054\u76df \u534f\u529e\uff1aMIT CSSA \u5609\u5bbe\u4ecb\u7ecd\uff1a Dr. Yuan-Hua Ding is a Senior Director and Head of Pfizer External R&#038;D Innovation (ERDI) &#8211; Asia\/Pacific, Pfizer Worldwide Research &#038; Development (WRD). He is [&hellip;]<\/p>\n","protected":false},"author":658,"featured_media":718,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-144","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-thaaevents","category-professionaldev"],"_links":{"self":[{"href":"https:\/\/tsinghua-boston.org\/wp-based\/wp-json\/wp\/v2\/posts\/144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tsinghua-boston.org\/wp-based\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tsinghua-boston.org\/wp-based\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tsinghua-boston.org\/wp-based\/wp-json\/wp\/v2\/users\/658"}],"replies":[{"embeddable":true,"href":"https:\/\/tsinghua-boston.org\/wp-based\/wp-json\/wp\/v2\/comments?post=144"}],"version-history":[{"count":0,"href":"https:\/\/tsinghua-boston.org\/wp-based\/wp-json\/wp\/v2\/posts\/144\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tsinghua-boston.org\/wp-based\/wp-json\/wp\/v2\/media\/718"}],"wp:attachment":[{"href":"https:\/\/tsinghua-boston.org\/wp-based\/wp-json\/wp\/v2\/media?parent=144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tsinghua-boston.org\/wp-based\/wp-json\/wp\/v2\/categories?post=144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tsinghua-boston.org\/wp-based\/wp-json\/wp\/v2\/tags?post=144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}